246
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clonal groups of extended-spectrum β-lactamase and biofilm producing uropathogenic Escherichia coli in Iran

, ORCID Icon & ORCID Icon

References

  • Flores-Mireles AL, Walker JN, Caparon M, et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284.
  • Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am. 2014;28(1):1–13.
  • Soto SM, Smithson A, Horcajada JP, et al. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect. 2006;12(10):1034–1036.
  • Soto SM, Smithson A, Martinez JA, et al. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol. 2007;177(1):365–368.
  • Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135–138.
  • Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, et al. Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrob Resist Infect Control. 2016;5(1):11.
  • Shanmugam N, Baker MODG, Ball SR, et al. Microbial functional amyloids serve diverse purposes for structure, adhesion and defence. Biophys Rev. 2019;11(3):287–302.
  • Bischoff S, Walter T, Gerigk M, et al. Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018;18(1):56.
  • Ramos NL, Dzung DT, Stopsack K, et al. Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries. Eur J Clin Microbiol Infect Dis. 2011;30(12):1587–1593.
  • Mohajeri P, Darfarin G, Farahani A. Genotyping of ESBL producing uropathogenic Escherichia coli in west of Iran. Int J Microbiol. 2014;2014:276941.
  • Haghighatpanah M, Mozaffari Nejad AS, Mojtahedi A, et al. Detection of extended-spectrum β-lactamase (ESBL) and plasmid-borne blaCTX-M and blaTEM genes among clinical strains of Escherichia coli isolated from patients in the north of Iran. J Glob Antimicrob Resist. 2016;7:110–113.
  • Jacoby GA. Genetics of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 1994;13(Suppl S1):S2–S11.
  • Jacoby GA. AmpC β-lactamases. Clin Microbiol Rev. 2009;22(1):161–182.
  • Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3(1):15–21.
  • Davari Abad E, Khameneh A, Vahedi L. Identification phenotypic and genotypic characterization of biofilm formation in Escherichia coli isolated from urinary tract infections and their antibiotics resistance. BMC Res Notes. 2019;12(1):796.
  • Raeispour M, Ranjbar R. Antibiotic resistance, virulence factors and genotyping of uropathogenic Escherichia coli strains. Antimicrob Resist Infect Control. 2018;7:118.
  • Ghadiri H, Vaez H, Razavi-Azarkhiavi K, et al. Prevalence and antibiotic susceptibility patterns of extended-spectrum ß-Lactamase and Metallo-ß-Lactamase–producing uropathogenic Escherichia coli isolates. Lab Med. 2014;45(4):291–296.
  • Kazemian H, Heidari H, Ghanavati R, et al. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Med Princ Pract. 2019;28(6):547–551.
  • Versalovic J, Schneider M, De Bruijn FJ, et al. Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reaction. Methods Mol Cell Biol. 1994;5(1):25–40.
  • Li W, Raoult D, Fournier PE. Bacterial strain typing in the genomic era. FEMS Microbiol Rev. 2009;33(5):892–916.
  • Rademarker Jan.L.W, de Bruijn Frans.J. Characterization and classification of microbes by rep-PCR genomic fingerprinting and computer assisted pattern analysis Caetano-Anollés, Gustavo, and Gresshoff, Peter M. In: DNA markers: protocols, applications, and overviews. New York: John Wiley & Sons; 1997. p. 151–171.
  • Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–1315.
  • Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, et al. Prevalence of UTI among patients attending dalhatu araf specialist hospital, Lafia, Nasarawa State, Nigeria. Int J Med Sci. 2009;1:163–167.
  • Smyth ET, McIlvenny G, Enstone JE, et al. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect. 2008;69(3):230–248.
  • August SL, De Rosa MJ. Evaluation of the prevalence of urinary tract infection in rural Panamanian women. PLoS One. 2012;7(10):e47752.
  • MacFaddin JF. Biochemical tests for identification of medical bacteria. Philadelphia: Lippincott Williams & Wilkins; 2000.
  • Vareille M, de Sablet T, Hindré T, et al. Nitric oxide inhibits Shiga-toxin synthesis by enterohemorrhagic Escherichia coli. Proc Natl Acad Sci USA. 2007;104(24):10199–10204.
  • Romling U, Bian Z, Hammar M, et al. Curli fibers are highly conserved between salmonella typhimurium and Escherichia coli with respect to operon structure and regulation. J Bacteriol. 1998;180(3):722–731.
  • O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011;30(47):2437.
  • Stepanović S, Cirković I, Ranin L, et al. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett Appl Microbiol. 2004;38(5):428‐432.
  • Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing (CLSI supplement M100). 28th ed. Wayne, PA.; 2018.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
  • Kai-Larsen Y, Lüthje P, Chromek M, et al. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 2010;6(7):e1001010.
  • Dallenne C, Da Costa A, Decré D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495.
  • Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40(6):2153–2162.
  • Smith NC, Hennesy J, Stead DE. Repetitive sequence-derived PCR profiling using the BOX-A1 primer for rapid identification of plant pathogen Clavibacter michiganensis ssp. Eur J Plant Pathol. 2001;107(7):739–748.
  • Sneath PHA, Sokal RR. Numerical taxonomy: the principles and practice of numerical classification. San Francisco: WF Freeman & Co; 1973.
  • Askarian M, Mansour Ghanaie R, Karimi A, et al. Infectious diseases in Iran: a bird’s eye view. Clin Microbiol Infect. 2012;18(11):1081–1088.
  • De Souza GM, Neto ERDS, Da Silva AM, et al. Comparative study of genetic diversity, virulence genotype, biofilm formation and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from nosocomial and community acquired urinary tract infections. Infect Drug Resist. 2019;18:3595–3606.
  • Toval F, Köhler CD, Vogel U, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52(2):407–418.
  • Vollmerhausen TL, Katouli M. Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection. Eur J Clin Microbiol Infect Dis. 2014;33(6):975–982.
  • Brumbaugh AR, Mobley HL. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines. 2012;11(6):663–676.
  • Hanna A, Berg M, Stout V, et al. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl Environ Microbiol. 2003;69(8):4474–4481.
  • Saldaña Z, Xicohtencatl-Cortes J, Avelino F, et al. Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli. Environ Microbiol. 2009;11(4):992–1006.
  • Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37(4):291–295.
  • Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300(6):371–379.
  • Erb A, Stürmer T, Marre R, et al. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis. 2007;26(2):83–90.
  • Sannes MR, Kuskowski MA, Johnson JR. Geographical distribution of antimicrobial resistance among Escherichia coli causing acute uncomplicated pyelonephritis in the United States. FEMS Immunol Med Microbiol. 2004;42(2):213–218.
  • Moniri R, Khorshidi A, Akbari H. Emergence of multidrug resistant strains of Escherichia coli isolated from urinary tract infections. Iranian J Public Health. 2003;32:42–46.
  • Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, et al. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients. BMC Infect Dis. 2018;18(1):572.
  • Nozarian Z, Abdollahi A. Microbial etiology and antimicrobial susceptibility of bacteria implicated in urinary tract infection in Tehran, Iran. Iran J Pathol. 2015;10:54–60.
  • Keikha M, Rava M. Evaluation of antibiotic resistance of Escherichia coli strains isolated from urinary tract infections in outpatients referring to Nabi Akram Hospital in Zahedan. J Paramed Sci Rehabilit. 2017;6(4):73–78.
  • Lob SH, Nicolle LE, Hoban DJ, et al. Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014. Diagn Microbiol Infect Dis. 2016;85(4):459–465.
  • Shahbazi S, Asadi Karam MR, Habibi M, et al. Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist. 2018;14:118–125.
  • Nabti LZ, Sahli F, Radji N, et al. High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a tertiary care hospital in Sétif, Algeria. Microb Drug Resist. 2019;25(3):386–393.
  • Zhu FH, Rodado MP, Asmar BI, et al. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli in children: a case control study. Infect Dis. 2019;51(11–12):802–809.
  • Hashemizadeh Z, Kalantar-Neyestanaki D, Mansouri S. Clonal relationships, antimicrobial susceptibilities, and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolates from urinary tract infections and fecal samples in southeast Iran. Rev Soc Bras Med Trop. 2018;51(1):44–51.
  • Padmavathy K, Padma K, Rajasekaran S. Extended-spectrum β-lactamase/AmpC-producing uropathogenic Escherichia coli from HIV patients: Do they have a low virulence score? J Med Microbiol. 2013;62:345–351.
  • Eltai NO, Al Thani AA, Al-Ansari K, et al. Molecular characterization of extended spectrum β-lactamases Enterobacteriaceae causing lower urinary tract infection among pediatric population. Antimicrob Resist Infect Control. 2018;7:90.
  • Soltan Dallal M, Sabbaghi A, Molla Aghamirzaeie H, et al. Prevalence of AmpC and SHV β-lactamases in clinical isolates of Escherichia coli from Tehran hospitals. Jundishapur J Microbiol. 2013;6(2):176–180.
  • Ding H, Yang Y, Lu Q, et al. The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China. Eur J Clin Microbiol Infect Dis. 2008;27(10):915–921.
  • Polsfuss S, Bloemberg GV, Giger J, et al. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. J Clin Microbiol. 2011;49(8):2798–2803.
  • Uruén C, Chopo-Escuin G, Tommassen J, et al. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics. 2020;10(1):3.
  • Abdi S, Ranjbar R, Hakemi Vala M, et al. Frequency of bla TEM, bla SHV, bla CTX-M, and qnrA among Escherichia coli isolated from urinary tract infection. Arch Clin Infect Dis. 2014;9(1):e18690.
  • Karimi A, Rahbar M, Fallah F, et al. Detection of integron elements and gene groups encoding ESBLs and their prevalence in Escherichia coli and Klebsiella isolated from urine samples by PCR method. Afr J Microbiol Res. 2012;6(8):1806–1809.
  • Rastegar Lari A, Azimi L, Rahbar M, et al. Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: first report from Iran. Burns. 2013;39(1):174–176.
  • Gupta V, Garg R, Garg S, et al. Coexistence of Extended Spectrum Beta-Lactamases, AmpC Beta-Lactamases and Metallo-Beta-Lactamases in Acinetobacter baumannii from burns patients: a report from a tertiary care centre of India. Ann Burns Fire Disasters. 2013;26(4):189–192.
  • Pokhrel RH, Thapa B, Kafle R, et al. Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal. BMC Res Notes. 2014;7(1):694.
  • Krishnamurthy V, Vijaykumar GS, Kumar MS, et al. Phenotypic and genotypic methods for detection of extended spectrum β lactamase producing Escherichia coli and Klebsiella pneumoniae isolated from ventilator associated pneumonia. J Clin Diagn Res. 2013;7(9):1975–1978.
  • Andrei A, Zervos MJ. The application of molecular techniques to the study of hospital infection. Arch Pathol Lab Med. 2006;130(5):662–668.
  • Momtaz H, Karimian A, Madani M, et al. Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Ann Clin Microbiol Antimicrob. 2013;12:8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.